23 November 2017
News and Views
Links and Services
This month's Alimentary Pharmacology & Therapeutics investigates the long-term outcome of patients with polycystic liver disease treated with lanreotide.
Polycystic liver disease is a phenotypical expression of autosomal dominant polycystic kidney dis
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors